Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Peter Snyder, PhD
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system
A GuideStar-Rated Charity
© Copyright 2026. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).